![Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12]()
Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12Gnant, M.; Mlineritsch, B.; Stoeger, H.; Luschin-Ebengreuth, G.; Knauer, M.; Moik, M.; Jakesz, R.; Seifert, M.; Taucher, S.; Bjelic-Radisic, V.; Balic, M.; Eidtmann, H.; Eiermann, W.; Steger, G.; Kwasny, W.; Dubsky, P.; Selim, U.; Fitzal, F.; Hochreiner, G.; Wette, V.; Sevelda, P.; Ploner, F.; Bartsch, R.; Fesl, C.; Greil, R. · Annals of Oncology · 2015